← Every applicant
Carnegie FDA Approvals
10 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| LOMUSTINENew drugOct 27, 2025CAPSULE, ORAL |
| CLINDAMYCIN PHOSPHATENew drugJun 13, 2025SWAB, TOPICAL |
| BALSALAZIDE DISODIUMNew drugApr 3, 2025CAPSULE, ORAL |
| PRIMIDONENew drugJan 23, 2024TABLET, ORAL |
| FAMOTIDINENew drugJul 7, 2023FOR SUSPENSION, ORAL |
| VIGABATRINNew drugApr 28, 2023TABLET, ORAL |
| ETRAVIRINENew drugApr 13, 2022TABLET, ORAL |
| RASAGILINE MESYLATENew drugNov 18, 2021TABLET, ORAL |
| AMINOCAPROIC ACIDNew drugFeb 12, 2021TABLET, ORAL |
| AMINOCAPROIC ACIDNew drugJan 26, 2021SOLUTION, ORAL |